About the Company
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products. Hims & Hers operates with a direct-to-consumer model. Consumers consult licensed healthcare professionals and access treatments and products through the company's platform. Customers pay for a consultation with a doctor to prescribe the drug along with the price of the drug itself. The company has expanded its offerings to include health solutions for both men and women, along with mental health services.
Sector
Industrial Applications and Services
Industry
Services-Offices & Clinics of Doctors of Medicine
Employees
181
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Hims & Hers Health, Inc.
Meta's reported shake-up, Hims & Hers sinks on GoodRx–Novo deal
Meta (META) stock is dipping on reports that the company is restructuring its artificial intelligence (AI) unit for the ...
Hims & Hers down 2% as GoodRx expands Ozempic, Wegovy access
Shares of Hims & Hers (HIMS) are down 92c, or 2%, to $45.09 in pre-market trading after GoodRx (GDRX) announced that all strengths of Ozempic and Wegovy pens are available to eligible self-paying ...
US FTC investigating Hims & Hers over advertising and cancellation practices, Bloomberg News reports
The U.S. Federal Trade Commission is probing complaints about telehealth platform Hims & Hers regarding its advertising and ...
Hims & Hers Stock Slips As FTC Probe Into Subscription Practices Resurfaces
Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...
Hims & Hers Health's Transformation Into A Precision Health Platform
Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...
Why Hims & Hers Health Stock Just Dropped
At $13.6 billion in market capitalization, Hims & Hers stock costs a pricey 70 times trailing earnings. It's even more ...
Hims & Hers CEO sells $33 million in stock after a massive rally
Shares of Hims & Hers Health Inc. have roughly doubled over the past year — and Chief Executive Andrew Dudum cashed in on the ...
What's Next For HIMS Stock?
Hims & Hers stock (NASDAQ: HIMS) fell approximately 13% in after-hours trading following Q2 results that demonstrated strong ...
Sell HIMS Stock Ahead of Its Earnings?
In this photo illustration, a person holds a smartphone displaying the logo of Hims & Hers Health Inc. (NYSE: HIMS), an ...
CoreWeave, Applied Materials And Hims & Hers Are Among Top 10 Large Cap Losers Last Week (August 11-August 15): Are The Others In Your Portfolio?
Ten large-cap stocks, including CRWV, COHR & AMZN, were the worst performers last week. Weak results, downgrades, and FTC ...
Weight-Loss Drugs Telehealth Platform Hims & Hers Hit With New Lawsuit
On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...
Similar Companies
| Company | Ticker | 90 Days Forecast | Market Cap. (USD M) | P/E | P/B |
|---|---|---|---|---|---|
| Airsculpt Technologies, Inc. | AIRS | Predict | 390.54 | -68.82 | 4.28 |
| Hims & Hers Health, Inc. | HIMS | Predict | 945.54 | -14.34 | 2.89 |
| LifeMD, Inc. | LFMD | Predict | -62.12 | 0.00 | -205.89 |
| LifeMD, Inc. | LFMDP | Predict | -231.87 | 0.00 | -456.68 |
| SBC Medical Group Holdings Inc | SBC | Predict | 568.83 | None | 2.51 |
| SBC Medical Group Holdings Inc | SBCWW | Predict | 26.79 | None | 0.13 |
| Teladoc Health, Inc. | TDOC | Predict | 1328.09 | -1.77 | 0.93 |
| Oncology Institute, Inc. | TOI | Predict | 313.03 | -0.28 | 61.75 |
| Oncology Institute, Inc. | TOIIW | Predict | 2.27 | None | 0.15 |
Loading the latest forecasts...